Citius Oncology, Inc. CTOR Q1 2026 earnings
Reported February 13, 2026 · Before market open
Revenue estimate$4.4M
EPS estimate-$0.04
Next report
Aug 18, 2026 (in a month)Revenue estimate$5.8M
EPS estimate-$0.04
Financials
Q1 2026Valuation & ratios
Versus estimates
Revenue
Q2 2026$1.7MMiss by $5.3M
Q1 2026$3.9MMiss by $428.9K
Diluted EPS
Ask the moment Citius Oncology, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Citius Oncology, Inc. report Q1 2026 earnings?
- Citius Oncology, Inc. (CTOR) reported Q1 2026 earnings on February 13, 2026 before market open.
- What were Citius Oncology, Inc.'s Q1 2026 revenue and EPS?
- Citius Oncology, Inc. reported revenue of $3.9M and diluted EPS of $-0.06 for Q1 2026.
- Did Citius Oncology, Inc. beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $4.4M by $428.9K. EPS missed the consensus estimate of $-0.04 by $0.02.
- How did Citius Oncology, Inc.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS grew 45.5% from $-0.11.
- Where can I find Citius Oncology, Inc.'s Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001213900-26-015894) and the 10-Q periodic report (0001213900-26-015877) directly on SEC EDGAR. The filing index links above go to sec.gov.